Nutrition and LOComotoric Rehabilitation in Long COVID-19
UNLOCK
Faster Functional Performance Recovery After Individualized Nutrition Therapy Combined With a Patient-tailored Physical Rehabilitation Program Versus Standard Physiotherapy in Patients With Long COVID: a Pilot Study.
2 other identifiers
interventional
65
1 country
1
Brief Summary
Long COVID is a new phenomenon, in which individuals who experienced a SARS-CoV-2 infection still experience one or more symptoms, such as exercise intolerance, fatigue and/or muscle pains in addition to other COVID-related symptoms, weeks to months after initial infection. The aim of this pilot-study is to learn about which complaints patients continue to experience after their infection and how this affects their lives to a greater or lesser extent and whether a patient-tailored physical rehabilitation programme combined with individualised nutritional therapy leads to a faster recovery compared to a classic exercise program with the physiotherapist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable covid19
Started Apr 2022
Longer than P75 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2022
CompletedFirst Posted
Study publicly available on registry
February 24, 2022
CompletedStudy Start
First participant enrolled
April 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2024
CompletedMay 8, 2024
May 1, 2024
1.8 years
February 19, 2022
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1-minute sit-to-stand (1-MSTS)
Testing of endurance and muscle strength of the lower extremities (standing up from a sitting position for as many repetitions as possible during 1 minute)
Change from Baseline Repetitions Sit-To-Stand's in one minute at 12 weeks
Secondary Outcomes (5)
Multi-dimensional Fatigue Inventor (MFI-20)
Change from Baseline MFI-20 at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.
EuroQol five-dimensional (five-level version) (EQ-5D-5L)
Change from Baseline EQ-5D-5L at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.
Post-COVID-19 Functional Status (PCFS)
Change from Baseline PCFS at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.
Hospital Anxiety and Depression Scale (HADS)
Change from Baseline HADS at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.
Work Productivity and Activity Impairment (WPAI)
Change from Baseline WPAI at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.
Other Outcomes (8)
Muscle strength
Change from Baseline muscle strength at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.
Handgrip strength
Change from Baseline handgrip strength at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.
6-minute walk test (6-MWT)
Change from Baseline 6-MWT at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.
- +5 more other outcomes
Study Arms (2)
Personalized multimodal treatment
EXPERIMENTALA combination of biometric parameter oriented nutritional counseling and a tailored physical training program.
Standard care
ACTIVE COMPARATORPhysiotherapy with standard care advice for gradual cardiorespiratory and resistance training. (In this standard care setting, nutritional screening nor counseling is included.)
Interventions
This personalised multimodal treatment considers evidence- and practice-based elements (e.g., self-management, individual guidance \& follow-up, low-threshold activities, homebased functional training \& better follow-up guidance afterwards).
Eligibility Criteria
You may qualify if:
- Able to understand and sign written consent in Dutch, French or English
- Laboratory (PCR and/or serology) confirmed infection with SARS-CoV-2 less than 12 months ago
- Persisting functional difficulties and symptoms: exercise intolerance and/or fatigue and/or muscle pain beyond 12 weeks beside other COVID-related symptoms (e.g., loss of taste and/or smell)
- Patient affiliated to a social security system
You may not qualify if:
- Patients unable to comprehend oral and/or written instructions, questionnaires in English, French or Dutch.
- Patient currently suffers from any other disease beside long COVID that could explain the symptoms (e.g., fibromyalgia, Sjögren disease, severe anaemia...)
- Patient is unable to undergo a rehabilitation programme due to comorbidities (e.g., major cardiovascular disease such as myocarditis or severe dementia), as decided on by the medical study team members.
- Patient currently benefiting from physiotherapy sessions with focus on motor and/or respiratory therapy for COVID-19 or any other unrelated disease
- Patients with metabolic disorders or severe gastro-intestinal conditions (e.g. short bowel syndrome)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitair Ziekenhuis Brussellead
- Vrije Universiteit Brusselcollaborator
Study Sites (1)
Universitair ziekenhuis Brussel
Brussels, 1090, Belgium
Related Publications (1)
Roggeman S, Jimenez Garcia BG, Leemans L, Demol J, Geers J, De Smedt A, Putman K, Schiltz M, Beckwee D, De Waele E. Functional performance recovery after individualized nutrition therapy combined with a patient-tailored physical rehabilitation program versus standard physiotherapy in patients with long COVID: a pilot study. Pilot Feasibility Stud. 2023 Sep 28;9(1):166. doi: 10.1186/s40814-023-01392-1.
PMID: 37759324DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elisabeth De Waele, MD, PhD
Universitair Ziekenhuis Brussel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 19, 2022
First Posted
February 24, 2022
Study Start
April 24, 2022
Primary Completion
January 30, 2024
Study Completion
January 30, 2024
Last Updated
May 8, 2024
Record last verified: 2024-05